Page last updated: 2024-12-05
diethylene glycol dimethacrylate monomer
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 16891 |
CHEMBL ID | 3186638 |
SCHEMBL ID | 24260 |
MeSH ID | M0137210 |
Synonyms (61)
Synonym |
---|
di(ethylene glycol) dimethacrylate, 95% |
diethylene glycol bis(methacrylate) |
tgm 2 |
methacrylic acid, oxydiethylene ester |
dgm 2 |
oxydiethylene methacrylate |
diethylene glycol dimethacrylate monomer |
diethylene glycol dimethacrylate |
oxydi-2,1-ethanediyl bismethacrylate |
diethyleneglycol dimethacrylate |
2-propenoic acid, 2-methyl-, oxydi-2,1-ethanediyl ester |
einecs 219-099-9 |
hsdb 5458 |
ccris 7050 |
2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate |
D1530 |
2358-84-1 |
2-propenoic acid, 2-methyl-, 1,1'-(oxydi-2,1-ethanediyl) ester |
unii-r42pui926f |
r42pui926f , |
tox21_301734 |
dtxsid8044882 , |
NCGC00256100-01 |
di(ethylene glycol) dimethacrylate |
cas-2358-84-1 |
dtxcid6024882 |
25101-18-2 |
FT-0624887 |
AKOS015903120 |
diethylene glycol dimethacrylate [inci] |
diethylene glycol bis(methacrylate) [hsdb] |
methacrylic acid, diester with diethylene glycol |
diethylene glycol, dimethacrylate |
2,2'-oxybisethanol dimethacrylate |
2,2'-oxydiethyl dimethacrylate |
light ester 2eg |
blemmer pde 100 |
SCHEMBL24260 |
diethyleneglycoldimethacrylate |
XFCMNSHQOZQILR-UHFFFAOYSA-N |
mfm-418 |
ageflex degdma |
3-oxapentane-1,5-diyl dimethacrylate |
2-[2-(methacryloyloxy)ethoxy]ethyl 2-methylacrylate # |
CHEMBL3186638 |
diethylene glycol dimethacrylate(8 cp(20 degrees c)) |
mfcd00014931 |
diethylene glycol dimethacrylate, (stabilized with mehq) |
di(ethylene glycol) dimethacrylate, 96% |
diethylene glycol dimethacrylate (stabilized with mehq) |
J-015158 |
2,2'-oxybis(ethane-2,1-diyl) bis(2-methylacrylate) |
129011-76-3 |
Q27287772 |
oxybis(ethane-2,1-diyl) bis(2-methylacrylate) |
BS-48957 |
oxybis(ethane-2,1-diyl)bis(2-methylacrylate) |
2-{2-[(2-methylprop-2-enoyl)oxy]ethoxy}ethyl 2-methylprop-2-enoate |
CS-W010276 |
E82986 |
2-methyl-2-propenoic acid oxidi-2,1-ethanediyl ester,homopolymer |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (4)
Potency Measurements
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 61.6448 | 0.0002 | 29.3054 | 16,493.5996 | AID743069; AID743078 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 61.6448 | 0.0237 | 23.2282 | 63.5986 | AID743222 |
activating transcription factor 6 | Homo sapiens (human) | Potency | 61.6448 | 0.1434 | 27.6121 | 59.8106 | AID1159516 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 54.4827 | 0.0006 | 27.2152 | 1,122.0200 | AID743202 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.12
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.12) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |